Bill > HF485

This bill establishes a pharmaceutical assistance program, including an insulin assistance account in the special revenue fund, fees and penalties, and appropriates money for the program. The key provisions of the bill are: 1. It amends existing law to require the Board of Pharmacy to provide information to medical practitioners and pharmacies on sources of lower-cost prescription drugs, including patient assistance programs, government-funded programs, and other resources. 2. It establishes an insulin assistance program administered by the Commissioner of Human Services to pay participating pharmacies for insulin dispensed to eligible individuals, with eligibility based on factors like income, insurance status, and lack of coverage for insulin. 3. It creates an insulin assistance account in the special revenue fund, funded by registration fees paid by insulin manufacturers, to support the insulin assistance program. 4. It imposes reporting requirements on insulin manufacturers and wholesalers, as well as penalties for non-compliance, with the fees deposited into the insulin assistance account. The bill aims to improve access to affordable insulin and other prescription drugs for Minnesotans who are uninsured or underinsured.

Budget and Finance, Business and Industry, Health and Social Services

https://www.revisor.mn.gov/bills/bill.php?b=House&f=HF0485&ssn=0&y=2019